Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Germany to reimburse colonoscopy:

This article was originally published in Clinica

Executive Summary

German health minister Ulla Schmidt has welcomed a move by the federal committee of doctors and sickness funds to approve colonoscopy as a reimbursable procedure for the prevention of intestinal cancer. "This new move means that those aged 56 and over will now be eligible for two colonoscopies," she said. Intestinal cancer is the second most prevalent form of cancer amongst women and the third amongst men in Germany. It is furthermore the second most common cause of death from cancer in Germany, with some 30,000 deaths each year.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT067091

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel